Cargando…

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics

BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still suffer from a relapse. The main objective of this study was to identify proteomic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gámez-Pozo, Angelo, Trilla-Fuertes, Lucía, Prado-Vázquez, Guillermo, Chiva, Cristina, López-Vacas, Rocío, Nanni, Paolo, Berges-Soria, Julia, Grossmann, Jonas, Díaz-Almirón, Mariana, Ciruelos, Eva, Sabidó, Eduard, Espinosa, Enrique, Fresno Vara, Juan Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464546/ https://www.ncbi.nlm.nih.gov/pubmed/28594844 http://dx.doi.org/10.1371/journal.pone.0178296

Ejemplares similares

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
por: Rojas L, Katerin, et al.
Publicado: (2019)

Functional proteomics outlines the complexity of breast cancer molecular subtypes
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017)

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019)

Melanoma proteomics suggests functional differences related to mutational status
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019)

Bayesian networks established functional differences between breast cancer subtypes
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities
por: López-Camacho, Elena, et al.
Publicado: (2023)

Molecular characterization of breast cancer cell response to metabolic drugs
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2018)

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
por: Zapater-Moros, Andrea, et al.
Publicado: (2018)

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019)

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)

Urothelial cancer proteomics provides both prognostic and functional information
por: de Velasco, Guillermo, et al.
Publicado: (2017)

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023)

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
por: Gámez-Pozo, A, et al.
Publicado: (2011)

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023)

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2021)

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2022)

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2012)

The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy
por: Gámez-Pozo, Angelo, et al.
Publicado: (2014)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Assessment and Prediction of Human Proteotypic Peptide Stability for Proteomics Quantification
por: Chiva, Cristina, et al.
Publicado: (2023)

Dataset of the Botrytis cinerea phosphoproteome induced by different plant-based elicitors
por: Liñeiro, Eva, et al.
Publicado: (2016)

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
por: Sánchez-Navarro, Iker, et al.
Publicado: (2010)

QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories
por: Chiva, Cristina, et al.
Publicado: (2018)

MALDI Profiling of Human Lung Cancer Subtypes
por: Gámez-Pozo, Angelo, et al.
Publicado: (2009)

Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer
por: Espinosa, Enrique, et al.
Publicado: (2009)

Quality standards in proteomics research facilities: Common standards and quality procedures are essential for proteomics facilities and their users
por: Chiva, Cristina, et al.
Publicado: (2021)

Updated MS²PIP web server supports cutting-edge proteomics applications
por: Declercq, Arthur, et al.
Publicado: (2023)

The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?(†)
por: Vara-Ciruelos, Diana, et al.
Publicado: (2019)

Origins of De Novo Genes in Human and Chimpanzee
por: Ruiz-Orera, Jorge, et al.
Publicado: (2015)

Adjuvant vitamin C for sepsis: mono or triple?
por: Spoelstra–de Man, Angelique M. E., et al.
Publicado: (2019)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
por: Belbin, Olivia, et al.
Publicado: (2020)

Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells
por: Sánchez, Belén G., et al.
Publicado: (2020)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

The advance of adjuvant treatment for triple-negative breast cancer
por: Ge, Jingyu, et al.
Publicado: (2022)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

Two triple two-fold gated coincidence units
por: Nanni, Franco, et al.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_6sha5g9iou634nohient6cuc2f